Post job

Vericel Corp CEO and executives

Executive Summary. Based on our data team's research, Dominick C. Colangelo is the Vericel Corp's CEO. Vericel Corp has 216 employees, of which 20 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Vericel Corp executive team is 20% female and 80% male.
  • 69% of the management team is White.
  • 12% of Vericel Corp management is Hispanic or Latino.
  • 11% of the management team is Black or African American.
Work at Vericel Corp?
Share your experience

Rate Vericel Corp's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Dominick C. Colangelo

President & CEO

Mr. Dominick C. Colangelo joined Promedior in December 2008 with fifteen years of pharmaceutical industry experience, including nearly a decade with Eli Lilly and Company. During his career, Mr. Colangelo has held a variety of executive positions of increasing responsibility in finance, product development, pharmaceutical operations, and corporate business development. During his tenure at Eli Lilly and Company, Mr. Colangelo held positions as an international tax attorney in the finance organization and as Director of Strategy and Business Development for Lilly’s Diabetes and Growth Disorders Product Group. He also served as a founding Managing Director of Lilly Ventures. Mr. Colangelo received a B.S.B.A. degree in Accounting from the State University of New York at Buffalo and a J.D. degree from the Duke University School of Law.

Bernhard Palsson

Founder

Kevin F. McLaughlin

Board Member

Lisa Wright

Board Member

Paul Kevin Wotton

Board Member

Robert L. Zerbe

Chairman

Alan L. Rubino

Board Member

Heidi M. Hagen

Board Member

Steven C. Gilman

Board Member

Jonathan Mark Hopper

Chief Medical Officer

Jonathan Mark Hopper's LinkedIn

Jon Hopper is a Chief Medical Officer at VERICEL CORP and is based in Cambridge, Massachusetts. He has worked as Lecturer in Anatomy at University of Birmingham, Trauma & Orthopaedic Surgeon at General Hospital Birmingham, and Trauma Team II at Birmingham Accident Hospital. Jonathan works or has worked as FELLOW at ROYAL COLLEGE OF SURGEONS OF EDINBURGH. He attended Weston Favell Upper School between 1977 and 1981, University of Birmingham between 1981 and 1987, and University of Birmingham Medical School.

Do you work at Vericel Corp?

Does the leadership team provide a clear direction for Vericel Corp?

Vericel Corp jobs

Vericel Corp founders

Name & TitleBio
Bernhard Palsson

Founder

Vericel Corp board members

Name & TitleBio
Dominick C. Colangelo

President & CEO

Mr. Dominick C. Colangelo joined Promedior in December 2008 with fifteen years of pharmaceutical industry experience, including nearly a decade with Eli Lilly and Company. During his career, Mr. Colangelo has held a variety of executive positions of increasing responsibility in finance, product development, pharmaceutical operations, and corporate business development. During his tenure at Eli Lilly and Company, Mr. Colangelo held positions as an international tax attorney in the finance organization and as Director of Strategy and Business Development for Lilly’s Diabetes and Growth Disorders Product Group. He also served as a founding Managing Director of Lilly Ventures. Mr. Colangelo received a B.S.B.A. degree in Accounting from the State University of New York at Buffalo and a J.D. degree from the Duke University School of Law.

Kevin F. McLaughlin

Board Member

Lisa Wright

Board Member

Paul Kevin Wotton

Board Member

Robert L. Zerbe

Chairman

Alan L. Rubino

Board Member

Heidi M. Hagen

Board Member

Steven C. Gilman

Board Member

Vericel Corp executives FAQs

Zippia gives an in-depth look into the details of Vericel Corp, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Vericel Corp. The employee data is based on information from people who have self-reported their past or current employments at Vericel Corp. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Vericel Corp. The data presented on this page does not represent the view of Vericel Corp and its employees or that of Zippia.

Vericel Corp may also be known as or be related to VERICEL CORP, Vericel, Vericel Corp and Vericel Corporation.